Contact us   |  

Webinars program

Educational webinars for health professionals

ERN-EuroBloodNet is aware of the high impact that the online activities have nowadays, especially in the area of education. Topic specific recorded video sessions provided by experts in the field allow health professionals and patients to learn highly specialized knowledge without the need to travel and whenever they wish. In addition, topic focused webinars allow to tackle questions gathered from the audience in real time, providing the perfect environment to nourish from the most outstanding experts in the field.

ERN-EuroBloodNet Thursdays Webinars

The aim of these online educational activities is to contribute to continuing medical development requirements of health professionals, assisting them to provide cutting-edge knowledge on very rare diseases and highly specialised procedures, avoiding the general speech around a rare disease, but focussing on a very innovative and specific disease, clinic or intervention area.

Program

TOPICS  SUBNETWORK HUB EXPERTS
Recommendations on PKD diagnosis RBC NON ONCO Paola Bianchi
PKD Clinical management  RBC NON ONCO Eduard van Beers

Diagnosis microcytic anemias due to genetic disorders of iron metabolism or heme synthesis

HH-Iron NON ONCO Dorine Swinkels

Management of microcytic anemias due to genetic disorders of iron metabolism or heme synthesis

HH-Iron NON ONCO Graça Porto 
Diagnosis and management of CDA BMF NON ONCO Achille Iolascon
New treatments for Hemophilia Bleed-coag NON ONCO Mike Makris
Clinical management of rare forms of Hemochromatosis HH-Iron NON ONCO Domenico Girelli
Management of  Blackfan Diamond anemia in adults BMF NON ONCO Thierry Leblanc
Next Generation Sequencing based diagnosis, and Proteomics for the Haemoglobinopathies. RBC NON ONCO to be identified
BMF genetic diagnostic BMF NON ONCO Regis Peffault de la Tour
How to approach systemic mast cell disorders ?  MYEL ONCO Olivier Hermine  
Treatment of anemia of low risk MDS   MYEL ONCO Uwe Platzbecker 
Treatment of higher risk MDS after hypomethylating agent failure  MYEL ONCO Lionel Ades
When is molecular analysis useful in MDS ?  MYEL ONCO Valeria Santini
Treatment of AML in the elderly. Intensive or not ?   MYEL ONCO Gert Ossenkopele
When can "targeted therapy " be considered in AML  MYEL ONCO Christian Récher
Management of refractory ALL in adults MYEL ONCO Nicolas Boissel
Chronic myelomonocytic leukemia MYEL ONCO Raphael Itzykson
Atypical CML MYEL ONCO Nick Cross
Primary myelofibrosis: diagnosis and treatment   MYEL ONCO Jean Jacques Kiladjian 
Genetic predisposition to myeloid disorders: when to analyze it ?  MYEL ONCO J Fitzgibbon
HTLV1 infection related lymphomas LYMPH ONCO Olivier Hermine  
T-LPL LYMPH ONCO Olivier Tournihac 
Treatment of Cutaneous lymphomas  LYMPH ONCO Martine Bagot
Treatment of Amyloidosis  LYMPH ONCO Stefan Schoenland 
Genetic counselling of Hemophilia Bleed-coag NON ONCO Patricia Aguilar Martinez
Marginal zone lymphomas  LYMPH ONCO C. Thieblemont
CNS and/or Ocular lymphoma : A. Ferreri (I)/ Choquet (fr) / Soussain (Fr) LYMPH ONCO Soussain
How to approach older patient with CLL LYMPH ONCO D Bron

Past webinars

Past webinars can be downloaded here

TOPICS  SUBNETWORK HUB EXPERTS
Recommendations on PKD diagnosis RBC NON ONCO Paola Bianchi
PKD Clinical management  RBC NON ONCO Eduard van Beers
Diagnosis microcytic anemias due to genetic disorders of iron metabolism or heme synthesis HH-Iron NON ONCO Dorine Swinkels
Management of microcytic anemias due to genetic disorders of iron metabolism or heme synthesis HH-Iron NON ONCO Graça Porto 
Diagnosis and management of CDA BMF NON ONCO Achille Iolascon

Euro Blood Net